Who are we?
In 2019, Medicines Discovery Catapult joined forces with Cystic Fibrosis Trust to form the Cystic Fibrosis Syndicate in Antimicrobial Resistance. The Syndicate expanded, welcoming LifeArc in a tripartite managing partnership. The CF Syndicate in AMR is a cross-sector initiative that brings together leading experts in CF/AMR from industry, academia, and the clinic with people with Cystic Fibrosis.
![AMR Syndicate HP-04 AMR Syndicate HP-04](https://cfamr.org.uk/wp-content/uploads/2021/10/AMR-Syndicate-HP-04.png)